|
Feb 17
|
Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?
|
|
Feb 15
|
Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes
|
|
Feb 13
|
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
|
|
Feb 13
|
Merck & Co., Inc. (MRK): A Bull Case Theory
|
|
Feb 13
|
US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
|
|
Feb 12
|
Why Merck & Co., Inc. (MRK) is Declining
|
|
Feb 11
|
Jim Cramer on Merck & Co., Inc. (MRK): ‘Drug Stocks Are Really Getting Hurt’
|
|
Feb 11
|
Health Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant trea...
|
|
Feb 11
|
In the crowded cardio space, it’s David vs. Goliath for small biotechs
|
|
Jan 2
|
UK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal
|
|
Jan 1
|
The 5 worst-performing stocks on the Dow Jones Industrial Average in 2024
|
|
Dec 31
|
Is Merck & Co., Inc. (MRK) Among the Best Low Volatility Stocks to Buy Right Now?
|
|
Dec 31
|
Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 79%
|
|
Dec 30
|
Is Merck & Co., Inc. (MRK) the Best Pharma Dividend Stock to Buy In 2024?
|
|
Oct 16
|
Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Adults with Increased Risk for Pneumococcal Disease
|
|
Oct 15
|
Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment
|
|
Oct 15
|
Merck (MRK) Rises As Market Takes a Dip: Key Facts
|
|
Oct 15
|
Exelixis, MRK Collaborate for Combination Studies on HNSCC and RCC
|
|
Oct 14
|
erck & Co. (MRK): Winrevair Approval Drives Cardiovascular Growth
|
|
Oct 14
|
Exelixis and Merck Sign Clinical Development Collaboration to Evaluate Investigational Zanzalintinib in Combination with KEYTRUDA® (pembrolizumab) in Head and Neck Cancer and in Combination with WELIREG® (belzutifan) in Renal Cell Carcinoma
|